A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 10.1 EUR Market Closed
Market Cap: 85.9m EUR
Have any thoughts about
Apontis Pharma AG?
Write Note

Net Margin
Apontis Pharma AG

-10.3%
Current
-9%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.3%
=
Net Income
-6.6m
/
Revenue
63.8m

Net Margin Across Competitors

Country DE
Market Cap 84.1m EUR
Net Margin
-10%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 756.2B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 2.7T DKK
Net Margin
35%
Country US
Market Cap 350.6B USD
Net Margin
17%
Country US
Market Cap 252B USD
Net Margin
19%
Country CH
Market Cap 200.1B CHF
Net Margin
20%
Country UK
Market Cap 161.8B GBP
Net Margin
13%
Country CH
Market Cap 171.5B CHF
Net Margin
35%
Country US
Market Cap 151.5B USD
Net Margin
7%
No Stocks Found

Apontis Pharma AG
Glance View

Market Cap
84.1m EUR
Industry
Pharmaceuticals

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

APPH Intrinsic Value
17.03 EUR
Undervaluation 41%
Intrinsic Value
Price
A

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-10.3%
=
Net Income
-6.6m
/
Revenue
63.8m
What is the Net Margin of Apontis Pharma AG?

Based on Apontis Pharma AG's most recent financial statements, the company has Net Margin of -10.3%.